Ballentine Partners’s Archrock AROC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$311K Sell
10,261
-127
-1% -$4.31K ﹤0.01% 823
2026
Q2
$423K Buy
10,388
+402
+4% +$14.8K 0.01% 634
2026
Q1
$348K Buy
9,986
+5
+0.1% +$160 ﹤0.01% 671
2025
Q4
$260K Sell
9,981
-243
-2% -$6.04K ﹤0.01% 792
2025
Q3
$269K Sell
10,224
-28
-0.3% -$675 ﹤0.01% 778
2025
Q2
$255K Buy
10,252
+119
+1% +$2.92K ﹤0.01% 765
2025
Q1
$266K Buy
10,133
+575
+6% +$15.5K ﹤0.01% 670
2024
Q4
$238K Buy
+9,558
New +$221K ﹤0.01% 706
2020
Q1
– Sell
-10,175
Closed -$102K – 347
2019
Q4
$102K Buy
+10,175
New +$94.9K ﹤0.01% 401

Other funds holding AROC

Ballentine Partners's AROC Position: Q3 2026 in Review

Ballentine Partners reduced its Archrock (AROC) stake by 1.2% in Q3 2026, selling an estimated $4.31K and leaving 10,261 shares worth $311K. The position accounts for ﹤0.01% of the portfolio, ranked #823.

Ballentine Partners first reported a position in AROC in Q4 2019 and has held it in 9 quarters since. The position peaked at $423K in Q2 2026. 331 funds tracked by Wall St. Rank hold AROC as of Q3 2026.

  • Ballentine Partners held 10,261 shares of Archrock worth $311K as of Q3 2026.
  • Ballentine Partners sold 127 Archrock shares in Q3 2026, an estimated $4.31K.
  • Archrock made up ﹤0.01% of Ballentine Partners's portfolio in Q3 2026, its #823 holding.
  • Ballentine Partners first reported a position in Archrock in Q4 2019 and has held it in 9 quarters since.
  • Ballentine Partners's Archrock position peaked at $423K in Q2 2026.
  • 331 funds tracked by Wall St. Rank held Archrock as of Q3 2026.

Based on Ballentine Partners's 13F filing for Q3 2026, filed 13 Nov 2026.